Curcumin: Clinical Trials

70 trials of Curcumin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

34 completed, 14 unknown, 9 withdrawn, 6 terminated. 70 Phase 2, 14 Phase 1, 10 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 270Completed 34, Unknown 14, Withdrawn 9, Terminated 6, Not yet recruiting 4, Recruiting 2, Active not recruiting 1
Phase 114Completed 6, Unknown 4, Withdrawn 2, Recruiting 1, Terminated 1
Phase 310Completed 6, Unknown 4

Follow Curcumin: new trials by email Literature Review of Curcumin trials Research Report on Curcumin

Trials (filtered) newest first · largest first

All 70 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Curcumin Extract Added to Ciprofloxacin for Typhoid Carriers Among Food Handlers of the Free Nutritious Meal Program
Curcumin extract, Ciprofloxacin, Placebo - Typhoid Carrier, Typhoid Fever
Phase 2Not yet recruitingUniversitas Sebelas Maret1002026-11-022026-10-30
Cognitive Effects of Bioavailable Curcumin
Curcumin, Placebo - Memory, Cognitive Function Decline
Phase 2WithdrawnUniversity of California, Los Angeles2026-04-012026-05-01
A Phase II Single-Arm Study of High-Bioavailability Curcumin as Neoadjuvant Chemoradiotherapy in Mid-to-Low Rectal Cancer: Integrated Clinical and Translational Analysis of Tumor Tissue
Curcumin (BCM-95®) - Rectal Cancer, Locally Advanced Rectal Cancer
Phase 2Not yet recruitingChang Gung Memorial Hospital722026-01-012025-11-25
The Effect of Curcumin on Inflammatory Markers in Hemodialysis Patients
Curcumin (Longvida™), Placebo - Hemodialysis
Phase 2Not yet recruitingUniversity of Guadalajara702025-03-152025-02-17
RQC for the Prevention of Alzheimer's Disease and Retinal Amyloid-β
Resveratrol, Quercetin, and Curcumin (RQC), Curcumin - Alzheimer Disease, Mild Cognitive Impairment
Phase 2Not yet recruitingZaparackas and Knepper LTD2002024-07-012024-06-26
Evaluation of the Therapeutic Effects of Curcumin on Changes in Lipid, Metabolic, and Hormonal Profiles, Liver Enzyme Activity, and Ultrasonography Morphology of the Liver in Women With Polycystic Ovary Syndrome and Nonalcoholic Fatty Liver Disease: A Double-blind, Placebo-controlled Clinical Trial
Patients (women of reproductive age suffering from non-alcoholic fatty liver with polycystic ovary syndrome) receiving 500 mg curcumin capsules (prepared from the extraction of turmeric in the laborat - Polycystic Ovary Syndrome (PCOS) With Concurrent Nonalcoholic Fatty Liver Disease (NAFLD)
Phase 2 / Phase 3CompletedFateme Moshirenia742024-06-222025-12-11
Rationale and Design of Diabetes Management With Curcumin and Saffron (DMCS): a Randomised, Three Blind -Blind, Placebo-controlled Study
curcumin, saffron, Combination of saffron and curcumin and placebo - Women of Reproductive Age, Diabetes Mellitus
Phase 1 / Phase 2UnknownFateme Moshirenia1202024-06-102024-05-21
Single-Dose Pharmacokinetics of Oral Testosterone Undecanoate With and Without Concomitant Inhibition of UGT2B17
Relugolix 120Mg Tab, Curcumin, Testosterone Undecanoate 237 MG Oral Capsule - Hypogonadism, Male
Phase 1 / Phase 2UnknownUniversity of Washington102024-06-012024-03-15
Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms
Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Clonal Cytopenia of Undetermined Significance, Essential Thrombocythemia
Phase 2RecruitingUniversity of Southern California302024-03-012026-03-27
Role of Curcumin in Paclitaxel Induced PN
Curcumin, Paclitaxel - Chemotherapy-induced Peripheral Neuropathy
Phase 2UnknownAin Shams University802023-08-302023-07-28
Effect of Hebal and Synthetic Medicamentss on Enterococcus Feacalis
Ibuprofen 400 mg., modified triple antibiotic paste, curcumin - Effective Intracanal Medicaments Against Enterococcus Faecalis
Phase 2 / Phase 3UnknownTanta University322023-08-262023-08-23
Curcumin's Effect on Diabetic Patients With Atherosclerotic Cardiovascular Risk
Puritans Pride Turmeric curcumin® 500 mg - Diabetes Mellitus, Type 2, Dyslipidemias
Phase 2CompletedAin Shams University722023-07-012025-08-22
Clinical Study of Curcumin in Preventing Postoperative Adhesion of Bilateral Vocal Cords
Curcumin, Mitomycin-C - Glottic Web of Larynx, Laryngeal Stenosis
Phase 1 / Phase 2RecruitingEye & ENT Hospital of Fudan University1002023-05-052023-05-06
The Effect of Curcumin on the Clinical Outcome of Pediatric Patients with Active Lupus Nephritis
Curcumin Oral Capsule - Lupus Nephritis, SLE Nephritis
Phase 2CompletedAin Shams University722023-04-012024-11-20
The Effect of Oral Nanocurcumin as an Adjuvant Therapy for Anogenital Warts: Evaluation of Clinical Improvement, NFĸB, IFN-γ, and FOXP3+TReg From Lesions Tissue
Curcumin Oral Capsule, Trichloroacetic acid, Blood sample collection - Anogenital Wart
Phase 2 / Phase 3CompletedUniversitas Indonesia782022-08-162024-02-28
KurCoSmart Effects on People With Type 2 DM
Curcumin and virgin coconut oil extract (KurCo Smart) - Diabetes Mellitus, Type 2, Insulin Resistance
Phase 1 / Phase 2UnknownUniversitas Sebelas Maret402022-06-012022-06-07
Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer
Curcumin plus Piperine - Prostate Cancer, Multiple Myeloma
Phase 2CompletedUniversity of Rochester302021-12-142026-05-12
Curcumin in Advanced Cervical Cancer
Curcumin, Placebo oral tablet - Cervical Cancer, Stage IIB
Phase 2WithdrawnInstituto Nacional de Cancerologia, Columbia2021-12-012022-12-07
Efficacy and Safety of Intravitreal Injection of Bevacizumab with and Without Oral Curcumin
bevacizumab with oral curcumin, bevacizumab with oral placebo - Diabetic Macular Edema, Macular Edema
Phase 2 / Phase 3UnknownIsfahan University of Medical Sciences522021-10-102024-09-19
A Study to Evaluate the Safety and Efficacy of RQC for AMD
Resveratrol, Quercetin, Curcumin (RQC), Curcumin - Age-related Macular Degeneration
Phase 2CompletedPaul A Knepper, MD PhD552021-10-042025-07-30

Showing 20 of 70. Sign in to see all of them.

Conditions studied

Breast Neoplasms (6)  ·  Diabetes Mellitus, Type 2 (5)  ·  Cognitive Dysfunction (4)  ·  Diabetes Mellitus (4)  ·  Renal Insufficiency, Chronic (4)  ·  Inflammation (3)  ·  Adenomatous Polyposis Coli (2)  ·  Alzheimer Disease (2)  ·  Colorectal Neoplasms (2)  ·  Motor Activity (2)  ·  Multiple Myeloma (2)  ·  Myelodysplastic Syndromes (2)  ·  Neoplasms (2)  ·  Pancreatic Neoplasms (2)  ·  Prostatic Neoplasms (2)

Sponsors

M.D. Anderson Cancer Center (5)  ·  Ain Shams University (4)  ·  National Cancer Institute (NCI) (3)  ·  University of Rochester (3)  ·  Centre Jean Perrin (2)  ·  Fateme Moshirenia (2)  ·  National Nutrition and Food Technology Institute (2)  ·  Universitas Sebelas Maret (2)  ·  University of California, Los Angeles (2)  ·  Amy Beres (1)  ·  Andrew H Miller (1)  ·  Chang Gung Memorial Hospital (1)  ·  Chinese University of Hong Kong (1)  ·  Diana Jalal (1)  ·  Eye & ENT Hospital of Fudan University (1)

Countries

United States (22)  ·  Iran (5)  ·  Egypt (3)  ·  France (3)  ·  Indonesia (3)  ·  Canada (2)  ·  India (2)  ·  Mexico (2)  ·  Puerto Rico (2)  ·  Armenia (1)  ·  Belgium (1)  ·  China (1)  ·  Honduras (1)  ·  Hong Kong (1)  ·  Israel (1)

Top investigators

Paul A Knepper, MD, PhD (2)  ·  Abolfazl Razzaghdoust (1)  ·  Alice P Pentland, MD (1)  ·  Amit X Garg, MD, PhD (1)  ·  Andrew H Miller, MD (1)  ·  Anne L Thomas, PhD FRCS (1)  ·  Armen Tananyan, PhD (1)  ·  Benjamin I Goldstein, MD (1)  ·  Brea Lipe (1)  ·  Casey L O'Connell, MD (1)  ·  Dhimant Patel, MD (1)  ·  Diana Jalal (1)  ·  Elizabeth Balbin (1)  ·  Francis Giardiello (1)  ·  Francis M Giardiello, M.D. (1)

Results publications

PMID 18628464, PMID 10444409, PMID 11323096, PMID 11712783, PMID 12676044, PMID 17509812, PMID 17942826, PMID 17951067, PMID 18204357, PMID 18252805, PMID 19393114, PMID 19594223, PMID 19735878, PMID 20046768, PMID 20160040, PMID 20726007, PMID 21296615, PMID 21532153, PMID 21565893, PMID 21810420, PMID 23530101, PMID 24614693, PMID 24648302, PMID 25872567, PMID 25979230, PMID 26771294, PMID 26837852, PMID 27888116, PMID 28965778, PMID 29034576, PMID 29802852, PMID 2988769, PMID 30373740, PMID 30427093, PMID 30968152, PMID 31108984, PMID 31132111, PMID 31138229, PMID 32029014, PMID 34404358, PMID 34583214, PMID 35694030, PMID 35695002, PMID 35960332, PMID 36351465, PMID 36636059, PMID 38900570, PMID 39148307, PMID 39515198, PMID 40595276

NIH funding

2016 (1), 5KL2RR024136-03 (1), N01CN00042 (1), N01CN35160 (1), P30AG028740 (1), P30CA006973 (1), P30CA014089 (1), P30CA015083 (1), P30CA062203 (1), R01CA134620 (1), R21CA104337 (1), R21CA178603 (1), R21CA178648 (1), U10CA037420 (1), UG1CA189961 (1)